Skip to main content
Log in

Impact of the CYP2D6 metaboliser status on the pupillary response of tramadol—a commentary

  • Letter to the Editor
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Slanar O, Perlik F (2004) CYP2D6 polymorphism and miotic efect of tramadol in healthy volunteers. Drug Metab Rev 36:114

    Google Scholar 

  2. Slanar O, Nobilis M, Kvetina J, Idle JR, Perlik F (2005) CYP2D6 polymorphism, tramadol pharmacokinetics and pupillary response. Eur J Clin Pharmacol

  3. Knaggs RD, Crighton IM, Cobby TF, Fletcher AJ, Hobbs GJ (2004) The pupillary effects of intravenous morphine, codeine, and tramadol in volunteers. Anesth Analg 99:108–112

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fliegert, F., Kurth, B. & Göhler, K. Impact of the CYP2D6 metaboliser status on the pupillary response of tramadol—a commentary. Eur J Clin Pharmacol 62, 77–78 (2006). https://doi.org/10.1007/s00228-005-0040-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-005-0040-8

Keywords

Navigation